SpectraWAVE banks $50m for HyperVue coronary imaging system
SpectraWAVE has closed $50m in a Series B financing round for HyperVue, its cardiovascular imaging system cleared by the US …
SpectraWAVE has closed $50m in a Series B financing round for HyperVue, its cardiovascular imaging system cleared by the US …
Ireland is a vital location in the European medical equipment market. The value of the domestic market is expected to …
Researchhas found that artificial intelligence (AI) chest X-rays can detect the early symptoms of lung cancer up to three years …
SOPHiA GENETICS and AstraZeneca (AZ) have announced plans to accelerate the global rollout of liquid biopsy test, MSK-ACCESS. Powered by the …
Paragon 28 has expanded its APEX 3D Total Ankle Replacement System with a new Right-Angle Drill aimed at optimising tibia …
Medical technology company Smith+Nephew has announced the launch of its ‘TOTAL ANKLE Patient-Matched Guides’. These guides are designed to offer surgeons …
As the costs to develop and commercialise medical products rapidly rise, life science companies are increasingly looking for alternative funding …
Sonic Incytes Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its Velacur …
US-based medical technology company Catalyst OrthoScience has secured $20m in equity and venture debt financing. The funding round included contributions from …
Israel-based medtech startup Discure has secured $16m in Series A financing to advance its implantable device for treating degenerative disc …
CorFlow Therapeutics has raised $48.5m (€44m) in a Series B financing round to advance its microvascular obstruction (MVO) detection device …
The knee replacement market is undergoing a significant transformation, driven by groundbreaking innovations in technology and materials. The use of …
Biocaptiva, has announced that it has been granted its first US patent that covers anew liquid biopsy technology designed to …
AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic obstructive pulmonary …
Lunit has collaborated with Roche to improve precision medicine and improve cancer biomarker testing. Luni’s AI-powered tool, Lunit SCOPE PD-L1 22C3 …